epigallocatechin gallate has been researched along with Insulin Sensitivity in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (14.63) | 29.6817 |
2010's | 30 (73.17) | 24.3611 |
2020's | 5 (12.20) | 2.80 |
Authors | Studies |
---|---|
He, Y; Kong, Y; Ling, TJ; Wang, F; Wu, X; Yang, M; Zhang, J | 1 |
Chen, LH; Hu, XH; Wang, YF; Wu, M | 1 |
Lu, Y; Ren, Z; Yang, H; Yang, Z; Zhang, R | 1 |
Bao, S; Cao, Y; Hou, H; Yang, W | 1 |
Ali, TM; Faheem, NM | 1 |
Gao, B; Hui, S; Li, L; Lu, Y; Ma, SB; Miao, S; Shi, XP; Wen, AD; Zhang, R | 1 |
Flatt, PR; Gault, VA; Millar, PJB; Pathak, NM; Pathak, V | 1 |
Gao, Y; Huang, S; Li, R; Li, X; Liu, X; Mi, Y; Qi, G; Wang, Y | 1 |
Cheng, C; Feng, ZJ; Jiang, H; Liu, CM; Ma, JQ; Sun, JM; Yang, W | 1 |
Huang, S; Li, R; Li, X; Liu, X; Mi, Y; Qi, G; Tian, H; Zhang, W | 1 |
Bae, UJ; Chae, BM; Chae, SW; Jung, SJ; Oh, MR; Park, BH; Park, IW; Park, J; Ryu, GS | 1 |
Li, J; Liu, H; Liu, X; Mi, Y; Qi, G; Tian, H | 1 |
Guan, Y; Li, Y; Ling, F; Niu, Y; Wu, Y; Yuan, H; Zhang, C; Zhang, Q | 1 |
Bakhtiyari, S; Haghani, K; Khatami, M; Rashidinejad, A; Zaherara, M | 1 |
Ahn, S; Bae, JH; Bae, KC; Cho, HC; Choi, YJ; Im, SS; Kim, SP; Kim, YW; Park, JH; Song, DK | 1 |
Jang, HJ; Kim, JA; Ridgeway, SD | 1 |
Alcorta, P; Barrenechea, L; Labayen, I; Larrarte, E; Margareto, J; Mielgo-Ayuso, J | 1 |
Feng, Z; Hou, C; Liu, J; Long, J; Shen, W; Tang, Y; Wang, H; Yan, J; Zang, W | 1 |
Keske, MA; Kim, JA; Munir, K; Ng, HL; Premilovac, D; Quon, MJ; Rattigan, S; Yang, P | 1 |
Bao, S; Cao, Y; Li, L; Shan, Z; Teng, W; Yang, W; Zhang, J | 1 |
Deng, YP; Gan, L; Guo, JQ; Li, H; Lu, XC; Luo, BD; Meng, ZJ; Xiong, RB; Zheng, ZW; Zou, F | 1 |
Babakhani, A; Bakhtiyari, S; Haghani, K; Karimfar, MH | 1 |
do Nascimento, CO; Lira, F; Mennitti, L; Okuda, M; Oyama, L; Ribeiro, E; Santamarina, A; Santana, A; Seelaender, M; Souza, G; Venancio, D | 1 |
Chan, YC; Chang, SJ; Liu, HW; Wang, MF; Wei, CC | 1 |
Carvalho-Silva, M; do Nascimento, CM; Gomes, LM; Lira, FS; Okuda, MH; Oyama, LM; Ribeiro, EB; Santamarina, AB; Santana, AA; Seelaender, M; Streck, EL | 1 |
Bendik, I; Blaak, EE; de Groot, P; Goossens, GH; Jocken, JW; Most, J; Schrauwen, P; Timmers, S; van Boekschoten, M; Warnke, I | 1 |
Botelho, PB; de Morais, AC; Ferreira, MA; Mota, JF; Silva, DM | 1 |
Bluck, L; Brown, AL; Coverly, J; Coward, A; Hendrickx, H; Jackson, S; Lane, J; Stephen, A; Stocks, J | 1 |
Ashida, H; Fukuda, I; Nagayasu, H; Nishiumi, S; Ueda, M; Yoshida, K | 1 |
Hashimoto, O; Inoue, K; Koga, H; Nakamura, T; Nakayama, H; Otabe, S; Sata, M; Sivakumar, R; Torimura, T; Ueno, T; Yamada, K; Yuan, X | 1 |
Dai, XQ; Ding, Y; Li, Q; Li, Y; Liang, J; Wang, JB; Zhang, ZF | 1 |
Han, P; He, B; Li, Y; Wu, N; Zhang, W; Zhao, P; Zhao, S | 1 |
Chou, P; Hsu, CH; Huang, CJ; Liao, YL; Lin, SC; Tsai, TH | 1 |
Feng, Z; Liu, J; Long, J; Shen, W; Wang, Y; Weber, P; Wertz, K; Yan, J | 1 |
Chang, TW; Deng, YT; Lee, MS; Lin, JK | 1 |
Gradinaru, D; Ilie, M; Margina, D | 1 |
Guo, X; Huang, F; Liu, B; Liu, K; Shao, L; Wang, M | 1 |
Castellaneta, E; Cava, E; Ceccarelli, P; Claudia, S; Donini, LM; Edda, C; Emanuela, C; Faliva, M; Fioravanti, M; Klersy, C; Luciano, S; Maddalena, P; Opizzi, A; Paola, C; Paolini, M; Perna, S; Rondanelli, M; Savina, C; Scavone, L; Solerte, SB | 1 |
Colantuono, G; Federici, A; Kim, JA; Marasciulo, FL; Montagnani, M; Potenza, MA; Quon, MJ; Tarquinio, M; Tiravanti, E | 1 |
Wolfram, S | 1 |
Lin, CL; Lin, JK | 1 |
3 review(s) available for epigallocatechin gallate and Insulin Sensitivity
Article | Year |
---|---|
Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.
Topics: Adipose Tissue; Animals; Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Liver; Muscle, Skeletal; Nitric Oxide; Tea | 2015 |
Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review.
Topics: Animals; Antioxidants; Body Composition; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Inflammation; Insulin Resistance; Meta-Analysis as Topic; Obesity; Oxidative Stress; Phytotherapy; Randomized Controlled Trials as Topic; Risk Factors; Tea | 2016 |
Effects of green tea and EGCG on cardiovascular and metabolic health.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Endothelium, Vascular; Energy Metabolism; Humans; Insulin Resistance; Obesity; Tea | 2007 |
5 trial(s) available for epigallocatechin gallate and Insulin Sensitivity
Article | Year |
---|---|
Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Topics: Adult; Anti-Obesity Agents; Antioxidants; Body Mass Index; Camellia sinensis; Catechin; Diet, Reducing; Dietary Supplements; Double-Blind Method; Energy Metabolism; Female; Humans; Insulin Resistance; Liver; Metabolic Syndrome; Middle Aged; Obesity; Plant Extracts; Plant Leaves; Risk Factors; Spain; Young Adult | 2014 |
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
Topics: Adult; Blood Glucose; Catechin; Dietary Supplements; Double-Blind Method; Energy Metabolism; Fasting; Female; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Male; Mitochondria; Muscles; Obesity; Plant Extracts; Postprandial Period; Resveratrol; Stilbenes | 2016 |
Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.
Topics: Adult; Affect; Aged; Antihypertensive Agents; Catechin; Diastole; Dietary Supplements; Double-Blind Method; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Treatment Failure | 2009 |
Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial.
Topics: Adult; Antioxidants; Body Mass Index; Catechin; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Obesity; Prospective Studies; Tea; Treatment Outcome; Waist-Hip Ratio; Weight Loss; Young Adult | 2011 |
Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects.
Topics: Adipokines; Adult; Alkaloids; Benzodioxoles; Capsaicin; Carnitine; Catechin; Diet, Reducing; Dietary Supplements; Double-Blind Method; Female; Humans; Inflammation Mediators; Insulin Resistance; Male; Middle Aged; Overweight; Piperidines; Polyunsaturated Alkamides; Time Factors; Weight Loss; Young Adult | 2013 |
33 other study(ies) available for epigallocatechin gallate and Insulin Sensitivity
Article | Year |
---|---|
EGCG-derived polymeric oxidation products enhance insulin sensitivity in db/db mice.
Topics: Animals; Catechin; Diabetes Mellitus; Insulin Resistance; Kidney; Mice; Oxidation-Reduction | 2022 |
[Effect of epigallocatechin-3-gallate on liver lipid metabolism in rats with intrauterine growth restriction and related mechanism].
Topics: Animals; Catechin; Female; Fetal Growth Retardation; Insulin Resistance; Lipid Metabolism; Lipids; Liver; Pregnancy; Rats | 2020 |
Anti‑glycolipid disorder effect of epigallocatechin‑3‑gallate on high‑fat diet and STZ‑induced T2DM in mice.
Topics: Animals; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Endothelial Cells; Glycolipids; Hypercholesterolemia; Hyperlipidemias; Insulin Resistance; Lipids; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Sterol Regulatory Element Binding Protein 2; Streptozocin | 2020 |
Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Diet, High-Fat; Inflammation; Insulin Resistance; Liver; Liver Diseases; Phytotherapy; Rats, Sprague-Dawley; Signal Transduction; Tea; Toll-Like Receptor 4 | 2020 |
The counteracting effects of (-)-Epigallocatechin-3-Gallate on the immobilization stress-induced adverse reactions in rat pancreas.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Immobilization; Insulin Resistance; Male; Oxidative Stress; Pancreas; Rats; Rats, Wistar | 2021 |
Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
Topics: Animals; Catechin; Cell Line, Tumor; Glucose; Glycogen; Hep G2 Cells; Hepatocytes; Humans; Insulin; Insulin Resistance; Male; Mice; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction | 2017 |
Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiposity; Alanine Transaminase; Animals; Blood Glucose; Body Weight; Catechin; Corticosterone; Diabetes Mellitus, Experimental; Diet, High-Fat; Drug Therapy, Combination; Energy Intake; Exenatide; Glucose Tolerance Test; Glutathione Reductase; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Resistance; Interleukin-6; Mice, Obese | 2018 |
(-)-Epigallocatechin-3-gallate Ameliorates Insulin Resistance and Mitochondrial Dysfunction in HepG2 Cells: Involvement of Bmal1.
Topics: AMP-Activated Protein Kinases; Animals; ARNTL Transcription Factors; Catechin; Cells, Cultured; Circadian Clocks; Glucosamine; Glucose; Hep G2 Cells; Hepatocytes; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria, Liver; Oxidative Stress | 2017 |
Association of changes in ER stress-mediated signaling pathway with lead-induced insulin resistance and apoptosis in rats and their prevention by A-type dimeric epigallocatechin-3-gallate.
Topics: Animals; Apoptosis; Blood Glucose; Catechin; Cytochromes c; Dimerization; Diospyros; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Insulin; Insulin Resistance; Lead; Liver; Male; Metabolic Diseases; Oxidative Stress; Plant Extracts; Rats; Signal Transduction | 2017 |
EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition.
Topics: Active Transport, Cell Nucleus; Animals; Catechin; Heme Oxygenase-1; Humans; Insulin; Insulin Resistance; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Signal Transduction | 2018 |
Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
Topics: Animals; Catechin; Cell Survival; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Obesity; Phytotherapy; Plant Extracts; Sirtuin 1; Tea; Weight Gain | 2018 |
EGCG stimulates the recruitment of brite adipocytes, suppresses adipogenesis and counteracts TNF-α-triggered insulin resistance in adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipocytes, Beige; Adipogenesis; Animals; Catechin; Insulin Resistance; Mice; Obesity; Oxidative Stress; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Uncoupling Protein 1 | 2018 |
Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; Inflammation; Insulin Resistance; Oxidative Stress; Rats; Transfection | 2018 |
The Phosphorylation of IRS1
Topics: Animals; Catechin; Cell Line; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Muscle Fibers, Skeletal; Palmitates; Phosphorylation; Proto-Oncogene Proteins c-akt; Rosiglitazone; Tea | 2019 |
Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Obesity Agents; Caco-2 Cells; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucose Intolerance; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Plant Extracts; Polyethylene Glycols; Retinol-Binding Proteins, Plasma | 2013 |
Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cattle; Cells, Cultured; Diet, High-Fat; Endothelial Cells; Endothelium, Vascular; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Polyphenols; Tea | 2013 |
Acetylated FoxO1 mediates high-glucose induced autophagy in H9c2 cardiomyoblasts: regulation by a polyphenol -(-)-epigallocatechin-3-gallate.
Topics: Acetylation; Animals; Antioxidants; Autophagy; Biomarkers; Catechin; Cell Line; Cytosol; Forkhead Transcription Factors; Glucose; Insulin Resistance; Male; Myoblasts, Cardiac; Nerve Tissue Proteins; Polyphenols; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species | 2014 |
Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Glucose; Catechin; Cytokines; Diet, High-Fat; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Islets of Langerhans; Macrophages; Male; Pancreas; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2014 |
Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
Topics: Animals; Biomarkers; Blood Glucose; Camellia sinensis; Catechin; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulysin; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plants, Medicinal; Time Factors | 2015 |
Rosiglitazone, but not epigallocatechin-3-gallate, attenuates the decrease in PGC-1α protein levels in palmitate-induced insulin-resistant C2C12 cells.
Topics: Animals; Antioxidants; Catechin; Cell Line; Creatine Kinase; Glucose; Hypoglycemic Agents; Insulin Resistance; Mice; Muscle Fibers, Skeletal; Myoblasts; Palmitates; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2015 |
Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
Topics: Absorption, Physicochemical; Adipose Tissue, White; Adiposity; Animals; Anti-Obesity Agents; Biomarkers; Brazil; Camellia sinensis; Catechin; Diet, High-Fat; Dietary Supplements; Food Handling; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Male; Mice; Obesity; Plant Extracts; Plant Leaves; Random Allocation; Weight Gain | 2015 |
Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
Topics: Aging; Animals; Camellia sinensis; Catechin; Dietary Supplements; Fatty Liver; Female; Glucose; Glucose Transporter Type 4; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Muscle, Skeletal; Plant Extracts; Sterol Regulatory Element Binding Protein 1 | 2015 |
Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
Topics: Animals; Body Weight; Catechin; Cytokines; Diet, High-Fat; Dietary Supplements; Enzymes; Glucose Tolerance Test; Insulin Resistance; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Tea | 2015 |
Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle.
Topics: Androstadienes; Animals; Camellia sinensis; Catechin; Genistein; Glucose; Glucose Transporter Type 4; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle, Skeletal; Protein Transport; Rats; Rats, Sprague-Dawley; Wortmannin | 2008 |
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adipose Tissue; Animals; Catechin; Deoxyguanosine; Fatty Liver; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Mice; Mice, Transgenic; Sterol Regulatory Element Binding Protein 1 | 2009 |
Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition.
Topics: AMP-Activated Protein Kinases; Animals; Biological Transport; Camellia sinensis; Catechin; Cell Line; Cell Membrane; Dexamethasone; Flavonoids; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Glucose Transporter Type 4; Insulin Receptor Substrate Proteins; Insulin Resistance; Muscle Cells; Phenols; Phosphorylation; Phytotherapy; Plant Extracts; Polyphenols; Proto-Oncogene Proteins c-akt; Rats; Serine; Tea | 2010 |
Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo.
Topics: AMP-Activated Protein Kinases; Animals; Catechin; Drug Therapy, Combination; Fatty Acids, Nonesterified; Glucose Clamp Technique; Insulin; Insulin Resistance; Oxidative Stress; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction | 2011 |
Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate.
Topics: Animals; Autophagy; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Down-Regulation; Fasting; Hypoglycemic Agents; Insulin Resistance; Male; Mitochondria; Mitogen-Activated Protein Kinases; Muscle, Skeletal; Oxidative Stress; Rats; Tumor Suppressor Protein p53; Up-Regulation | 2012 |
Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells.
Topics: Animals; Catechin; Cell Line; Curcumin; Enzyme Activation; Fatty Acids, Nonesterified; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Muscle, Skeletal; Palmitic Acid; Phosphorylation; Polyphenols; Protein Kinase C; Serine; Signal Transduction; Tetradecanoylphorbol Acetate | 2012 |
Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells.
Topics: Adult; Aged; Anisotropy; Biomarkers; Cardiovascular Diseases; Catechin; Cell Membrane; Cell Polarity; Diabetes Mellitus, Type 2; Diet, Vegetarian; Female; Humans; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Leukocytes, Mononuclear; Male; Membrane Fluidity; Membrane Potentials; Middle Aged; Quercetin; Resistin | 2012 |
Opposite effects of quercetin, luteolin, and epigallocatechin gallate on insulin sensitivity under normal and inflammatory conditions in mice.
Topics: 3T3 Cells; Adipose Tissue; Animals; Biological Transport; Blood Glucose; Catechin; Cell Line; Culture Media, Conditioned; Glucose; Glucose Tolerance Test; I-kappa B Kinase; Inflammation; Insulin Receptor Substrate Proteins; Insulin Resistance; Luteolin; Macrophages; Male; Mice; Mice, Inbred ICR; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Quercetin | 2013 |
EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.
Topics: Animals; Blood Pressure; Catechin; Enalapril; Endothelium, Vascular; In Vitro Techniques; Insulin Resistance; Male; Mesenteric Veins; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WF; Tea; Vasodilator Agents | 2007 |
Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells.
Topics: Adaptor Proteins, Signal Transducing; Adenylate Kinase; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Glucose; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-akt; Signal Transduction | 2008 |